Dr Eun-Gyung Cho | Biomaterials | Best Researcher Award

Posted on by sciencefather

Dr Eun-Gyung Cho | Biomaterials | Best Researcher Award

Dr. Eun-Gyung Cho is a leading biomedical scientist specializing in extracellular vesicles (EVs), skin biology, and stem cell applications. She currently holds multiple leadership positions, including Director of the H&B Science Center at CHA Meditech Co., Ltd., Director of the Consumer Health 2 Center at CHA Advanced Research Institute, and Adjunct Associate Professor at CHA University. Her career bridges cutting-edge biomedical research with real-world therapeutic and cosmetic applications, particularly in skin regeneration, aging, and immunology. She has published over 50 scientific papers and filed more than 240 patents, demonstrating innovation and scientific excellence across academia and industry.

Dr Eun-Gyung Cho, CHA R&D Institute/CHABio group, South Korea

Profile

ORCID

SCOPUS

🎓 Education

Dr. Eun-Gyung Cho holds a strong academic foundation in biological sciences and biotechnology. She earned her Ph.D. in Biological Sciences from Seoul National University (1998–2002) 🧬🎓, where she specialized in molecular and cellular biology. Prior to that, she completed her M.S. in Life Science at GIST, Kwangju (1996–1998) 🔬📘, gaining expertise in bio-research and developmental biology. Her academic journey began with a B.S. in Agricultural Biology at Seoul National University (1992–1996) 🌱🧪, where she built her initial skills in genetics, plant science, and biotechnology. This educational pathway laid the groundwork for her exceptional career in biomedical innovation.

🏢 Professional Experience

Dr. Eun-Gyung Cho brings over two decades of dynamic experience across academia, research, and biotechnology innovation. She currently serves as Director at CHA Meditech and the CHA Advanced Research Institute, and is an Adjunct Associate Professor at CHA University 🏢🔬📚. Previously, she held senior leadership roles at Amorepacific Corporation, including Team Leader and Chief Scientist, where she led R&D in bio-cosmeceuticals and exosome-based technologies 💄🧫. Her global expertise is further enriched by postdoctoral research at the NIH and Sanford-Burnham Institute in the USA 🌍🧠. Dr. Cho’s career reflects a blend of scientific depth, leadership, and innovation 💡🧪.

🧖‍♀️ Research Experience

Dr. Eun-Gyung Cho has led a distinguished research career in extracellular vesicles (EVs), stem cell biology, and skin science across academia and industry. At CHA Meditech and Amorepacific, she developed innovative biomaterials including EV-based skin boosters, anti-aging formulations, and microbial-derived therapies 🧪🧖‍♀️🌿. Her postdoctoral work at Sanford-Burnham and NIH advanced neurogenesis, cell cycle regulation, and bio-signaling mechanisms 🧠🔬🧫. With over 240 patents and 40+ publications, she has made pioneering contributions in cosmeceuticals, dermaceuticals, and regenerative medicine 🌟📈💊. Her research bridges fundamental science with real-world applications in skin health and personalized biotherapy.

🔬 Research Focus

Dr. Eun-Gyung Cho’s research centers on extracellular vesicles (EVs) 🧫, particularly their roles in intercellular communication, drug delivery, and as biomaterials for dermatological therapy 💉🧴. She specializes in developing skin boosters and biostimulators using EVs, peptides, recombinant proteins, and stem cell-conditioned media 🧬. Her work extends to skin biology 🧖‍♀️—exploring melanogenesis, skin barrier function, and cutaneous immunity—and stem cell biology, including iPSC differentiation into skin and neural lineages 🌱🧠. With deep roots in molecular biology, she also investigates cell cycle regulation, tumorigenesis, and apoptosis, bridging fundamental science with regenerative and aesthetic medicine 🧪💡.

📚 Publications

Human Probiotic Lactobacillus paracasei-Derived Extracellular Vesicles Improve Tumor Necrosis Factor-α-Induced Inflammatory Phenotypes in Human Skin
Authors: Kwang-soo Lee, Yunsik Kim, Jin Hee Lee, Suji Shon, Aram Kim, An Vuong Quynh Pham, Chungho Kim, Dong Hyun Kim, Yoon-Keun Kim, Eun-Gyung Cho
Journal: Cells, 2023

Comparative Lipidomic Analysis of Extracellular Vesicles Derived from Lactobacillus plantarum APsulloc 331261 Living in Green Tea Leaves Using Liquid Chromatography-Mass Spectrometry
Authors: Hyoseon Kim, Minjung Kim, Kilsun Myoung, Wanil Kim, Jaeyoung Ko, Kwang Pyo Kim, Eun-Gyung Cho
Journal: International Journal of Molecular Sciences, 2020

Kojyl Cinnamate Ester Derivatives Increase Adiponectin Expression and Stimulate Adiponectin-Induced Hair Growth Factors in Human Dermal Papilla Cells
Authors: Phil June Park, Eun-Gyung Cho
Journal: International Journal of Molecular Sciences, 2019

Circadian Expression of TIMP3 Is Disrupted by UVB Irradiation and Recovered by Green Tea Extracts
Authors: Sunyoung Park, Eun-Soo Lee, Nok-Hyun Park, Kyeonghwan Hwang, Eun-Gyung Cho
Journal: International Journal of Molecular Sciences, 2019

Prof. Dr Yuan Xu | Biomaterials | Best Researcher Award

Posted on by sciencefather

Prof. Dr Yuan Xu | Biomaterials | Best Researcher Award

Prof. Dr. Yuan Xu is a renowned physician-scientist and Chief Physician at the China-Japan Friendship Hospital 🏥. Holding both an MD and PhD, he specializes in the integration of Traditional Chinese Medicine (TCM) and Western medicine 🔬🌱. He serves as Deputy Director of the National Center for Integrated Medicine and is a Master’s Supervisor guiding future clinicians 🎓🧑‍⚕️. As a former visiting scholar at Yale University, his global outlook informs research on rheumatology, fibromyalgia, and chronic disease care 🌍💡. With 48 publications, 12 SCI papers, and multiple funded projects, he is a leader in translational healthcare innovation 🧠🏆.

Prof. Dr Yuan Xu, China-Japan Friendship Hospital, China

Profile

SCOPUS

Education 🎓

Prof. Dr. Yuan Xu holds both an MD and a PhD, establishing a strong foundation in clinical medicine and biomedical research 🩺🔬. His dual training bridges Western medical science and Traditional Chinese Medicine (TCM), enabling an integrative approach to healthcare 🌍🌱. He further enriched his academic profile as a visiting scholar at Yale University, USA, where he engaged in global research collaboration and advanced clinical studies 🇺🇸📖. This diverse educational background equips him with a comprehensive and holistic view of medicine, fueling his innovative work in rheumatology and chronic disease treatment 💡🧠.

Experience 🏥

Prof. Dr. Yuan Xu is a seasoned Chief Physician at the China-Japan Friendship Hospital and serves as a Master’s Supervisor, nurturing the next generation of clinicians and researchers 🎓👨‍🏫. As Deputy Director at the National Center for Integrated Traditional Chinese and Western Medicine, he leads national initiatives merging TCM with modern medical science ⚕️🌿. Recognized as an Innovative Young Talent and a “New 125” TCM Leader, he also gained international exposure as a visiting scholar at Yale University 🌍📚. His career spans clinical care, policy leadership, and translational research in chronic disease management 🧠🦴.

Contributions 📖

Prof. Dr. Yuan Xu has made impactful contributions in three core research areas: the development of diagnostic and treatment protocols for rheumatoid arthritis using Traditional Chinese Medicine (TCM) 🌿🦴, the advancement of fibromyalgia care strategies 🧠💊, and the management of integrated TCM and Western medical systems 🏥⚖️. He has led 12 major research projects, securing over 10 million yuan in funding 💰📊. His academic output includes 48 publications, with 12 SCI-indexed papers, where he served as first or corresponding author ✍️🔍. His work bridges clinical care and scientific discovery in modern integrative medicine 🧬🩺.

Research Focus 🔬

Prof. Dr. Yuan Xu’s research primarily targets rheumatoid diseases, with a strong emphasis on rheumatoid arthritis and fibromyalgia syndrome 🦴🧬. His work integrates Traditional Chinese Medicine (TCM) and modern biomedical approaches to develop more effective diagnostic models and personalized treatments 🌱⚕️. He investigates immune system dysregulation, inflammatory pathways, and syndrome differentiation in chronic joint disorders 🔍💊. Through national and international collaborations, including with Yale University, he bridges ancient practices with advanced clinical research 🏥🌍. His translational focus ensures that findings directly improve patient outcomes in chronic rheumatologic care 📈🧑‍⚕️.

Publications 📚

Early prediction of bone destruction in rheumatoid arthritis through machine learning analysis of plasma metabolites
Authors: Wang Zihan, Lan Tianyi, Jiao Yi, Tao Qingwen, Xu Yuan
Journal: Arthritis Research and Therapy, 2025 🧠💉📊

Clinical Characteristics and Influencing Factors of Rheumatoid Arthritis in Patients with Cold Dampness Obstruction Syndrome
Authors: Chen Yanyu, Li Yanqi, Liu Longxiao, Xu Yuan, Tao Qingwen
Journal: Chinese Journal of Experimental Traditional Medical Formulae, 2025 🌿🦴📘

Integrated phytochemistry and network pharmacology analysis to reveal effective substances and mechanisms of Bushen Quhan Zhiwang decoction in the treatment of rheumatoid arthritis
Authors: Zhang Liubo, Yan Yu, Ma Ru, Tao Qingwen, Xu Yuan
Journal: Journal of Ethnopharmacology, 2024 🌱⚗️🔎

Prof. Dr Ramasamy Paulmurugan | Biomaterials | Best Researcher Award

Posted on by sciencefather

Prof. Dr Ramasamy Paulmurugan | Biomaterials | Best Researcher Award

Prof. Dr. Ramasamy Paulmurugan is a globally recognized biomedical scientist and Professor of Radiology at Stanford University School of Medicine 🏛️. With expertise in molecular imaging, nanomedicine, and gene therapy, his work focuses on cancer diagnostics and targeted therapeutics 🎯🧫. He leads the Cellular Pathway Imaging Laboratory, developing cutting-edge biosensors and nanoparticle-based delivery systems 💡🧪. Author of 145+ publications, he has received prestigious awards for innovation and research excellence 🏅📚. His interdisciplinary impact spans academia, clinical research, and biotechnology, making him a trailblazer in translational medicine and precision oncology 🌐⚕️.

Prof. Dr Ramasamy Paulmurugan, Stanford University, United States

Profile

SCOPUS

ORCID

GOOGLESCHOLAR

Education  🎓

Prof. Dr. Ramasamy Paulmurugan began his academic journey with a B.Sc. in Zoology, Botany, and Chemistry (1986–1989) from Madurai Kamaraj University, India 🐸🌿🧪. He pursued an M.Sc. in Biomedical Genetics (1989–1991) at the University of Madras, developing a strong foundation in genetic science and human biology 🧬🧠. He then earned a Ph.D. in Biomedical Genetics with specialization in Molecular Virology (1991–1997) from National Environmental Engineering Research Institute and University of Madras, India 🔬🦠. His education equipped him with the interdisciplinary knowledge and research skills essential for his impactful work in cancer biology and molecular medicine 💡⚕️.

Honors & Awards 🏅

Prof. Dr. Ramasamy Paulmurugan has received numerous prestigious awards throughout his career for outstanding contributions to biomedical science 🧬🧠. His accolades include the Best Research Fellow Award (1991) from CSIR-NEERI 🇮🇳, the Young Scientist Award (1999) from the Government of Kerala, and multiple Travel Awards from international imaging societies for best paper presentations in the USA and Germany ✈️📄. He was honored with the Distinguished Investigator Award (2018) by the Academy for Radiology & Biomedical Imaging Research 🧪 and recently received the SAASCR Outstanding Achievement Award (2025) for advancing Asian American cancer research 🌍🔬.

Experience  🏥

Prof. Dr. Ramasamy Paulmurugan has over three decades of research and academic experience across India and the United States 🌍. He began as a Junior and Senior Research Fellow in Molecular Virology in India (1991–1996) 🔬, later leading the Environmental Biotechnology Division at RGCB as Scientist B and C (1996–1999, 1999–2003) 🧫. He was a Visiting Scientist at UCLA (2001–2003) 🧠, then joined Stanford University, where he advanced from Senior Research Scientist to Professor of Radiology (2003–present) 🏛️. His roles have spanned molecular imaging, translational research, and biomedical innovation across prestigious global institutions 💡📈.

Book Chapter 📖

Prof. Dr. Ramasamy Paulmurugan has authored and co-authored over 27 book chapters, contributing to prestigious scientific volumes on molecular imaging, cancer biology, gene therapy, bioluminescence, and nanomedicine 📖🔬. His work spans publishers like Springer, Elsevier, Cambridge University Press, and World Scientific, reflecting his expertise in cutting-edge biomedical innovations 🌍📗. Topics include theranostics, glioblastoma resistance, protein-protein interaction imaging, microRNA therapy, and nanoparticle-based delivery systems for precision medicine 🎯💊. His chapters are widely cited and used globally in advanced medical research, showcasing his status as a thought leader in translational and molecular medicine 🧪🌟.

Conference Presentations 🌍🎤

Prof. Dr. Ramasamy Paulmurugan has presented over 220 abstracts at leading international conferences spanning oncology, molecular imaging, nanomedicine, and gene therapy 🧬🧠. His research has been showcased at AACR, WMIC, RSNA, IEEE, ASNR, and SPIE, reflecting sustained excellence and innovation across decades 🏛️🔬. Topics include molecular biosensors, microRNA therapy, nanoparticle delivery, ultrasound imaging, and cancer diagnostics. These presentations highlight collaborations with global experts and his role in pioneering translational research that bridges bench to bedside 🧪➡️🏥. His prolific and consistent contributions demonstrate global recognition and influence in biomedical innovation 🌐🏅.

Research Focus 🔬

Prof. Dr. Ramasamy Paulmurugan’s research centers on molecular imaging, nanomedicine, and gene-based therapies to combat cancer and metabolic diseases like diabetes 🧠⚕️. He pioneers in vivo imaging of protein–protein interactions, miRNA delivery, and biosensor technologies for real-time monitoring of disease pathways 🧬📸. His innovations include split-luciferase systems, cell membrane-coated nanocarriers, and redox-sensitive signaling tools for precision therapeutics 🎯🧪. Bridging molecular biology with biomedical engineering, his translational research focuses on targeted drug delivery, noninvasive diagnostics, and theranostic nanoparticles, contributing significantly to personalized medicine and cancer theranostics 💉🧠🌐.

Publications 📚

The fate and toxicity of Raman-active silica-gold nanoparticles in mice
Authors: A.S. Thakor, R. Luong, R. Paulmurugan, F.I. Lin, P. Kempen, C. Zavaleta, et al.
Journal: Science Translational Medicine, Vol. 3 (79), 79ra33

Noninvasive quantitative imaging of protein–protein interactions in living subjects
Authors: P. Ray, H. Pimenta, R. Paulmurugan, F. Berger, M.E. Phelps, M. Iyer, et al.
Journal: Proceedings of the National Academy of Sciences (PNAS), Vol. 99 (5), 3105–3110

The emerging role of redox-sensitive Nrf2–Keap1 pathway in diabetes
Authors: E. Bhakkiyalakshmi, D. Sireesh, P. Rajaguru, R. Paulmurugan, et al.
Journal: Pharmacological Research, Vol. 91, 104–114

Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer
Authors: T.Y. Wang, J.W. Choe, K. Pu, R. Devulapally, S. Bachawal, S. Machtaler, R. Paulmurugan, et al.
Journal: Journal of Controlled Release, Vol. 203, 99–108

Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging
Authors: M. Krishnan, J.M. Park, F. Cao, D. Wang, R. Paulmurugan, J.R. Tseng, et al.
Journal: FASEB Journal, Vol. 20 (1), 106–108

Firefly luciferase enzyme fragment complementation for imaging in cells and living animals
Authors: R. Paulmurugan, S.S. Gambhir
Journal: Analytical Chemistry, Vol. 77 (5), 1295–1302

Molecular imaging of drug-modulated protein-protein interactions in living subjects
Authors: R. Paulmurugan, T.F. Massoud, J. Huang, S.S. Gambhir
Journal: Cancer Research, Vol. 64 (6), 2113–2119

Detection of hepatitis E virus in raw and treated wastewater with the polymerase chain reaction
Authors: N. Jothikumar, K. Aparna, S. Kamatchiammal, R. Paulmurugan, et al.
Journal: Applied and Environmental Microbiology, Vol. 59 (8), 2558–2562

Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system
Authors: R. Paulmurugan, S.S. Gambhir
Journal: Analytical Chemistry, Vol. 79 (6), 2346–2353

Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics
Authors: R.J.C. Bose, R. Paulmurugan, J. Moon, S.H. Lee, H. Park
Journal: Drug Discovery Today, Vol. 23 (4), 891–899

Mr Mohammed Amine ZITOUNI | Biomaterials | Best Researcher Award

Posted on by sciencefather

Mr Mohammed Amine ZITOUNI | Biomaterials | Best Researcher Award

Mr. Mohammed Amine Zitouni is an Algerian researcher specializing in polymer chemistry and macromolecular organic chemistry. He was born on August 31, 1985, in Sabra, Tlemcen, Algeria. Currently pursuing a Ph.D. in Polymer Chemistry at the University of Tlemcen, he holds a strong academic foundation with a Magister degree and a postgraduate diploma in chemistry. Mr. Zitouni has engaged in both national and international scientific activities, including participation in major conferences across Algeria and Russia. His research focuses on novel hydrogel synthesis, polymeric drug delivery systems, and chitosan-based materials.

Mr Mohammed Amine ZITOUNI, Laboratory of Research on macromolecules, Department of Chemistry, Science Faculty, University of Tlemcen, Algeria

Profile

ORCID

🎓 Education

Mr. Mohammed Amine Zitouni has a strong academic foundation in chemistry and life sciences 📘🧪. He earned his Bachelor’s degree in Natural and Life Sciences in June 2003 🎓🌿. He then pursued a Postgraduate Diploma in Chemistry from the University of Tlemcen in September 2007 🧬🏫. In December 2010, he obtained a Magister’s degree specializing in Macromolecular Organic Chemistry and Physical Chemistry ⚗️📚. Currently, he is working toward a Ph.D. in Polymer Chemistry at the University of Tlemcen, focusing on advanced polymeric materials for biomedical applications 🔬📖. His education reflects a clear commitment to scientific advancement.

🌍 Scientific Activities

Mr. Mohammed Amine Zitouni has actively participated in national and international scientific forums 🌐. He presented at the 10th International Conference of the European Chitin Society in Russia and major Algerian conferences like the CIMPC’17 in Tlemcen and the National Seminar on Polymers in Bejaïa 🎤🧪. With one year in the university tutoring program and four years of teaching LMD ST practical work, he contributes to student development 🎓🧑‍🏫. His research led to international publications on chitosan/PVA hydrogels in Advanced Materials Research and Annales pharmaceutiques françaises, focusing on novel drug delivery systems 📄💊.

💻 Skills

Mr. Mohammed Amine Zitouni is a multilingual researcher with strong communication and technical skills 🌍🧠. He is a native Arabic speaker, and is proficient in reading and writing in French and English, including technical scientific English for academic and research purposes 📘📚. His language skills allow him to effectively engage with international research communities and contribute to global scientific discourse 🌐✍️. In addition, he possesses excellent computer skills, demonstrating a perfect command of software tools and digital platforms essential for scientific research, data analysis, and academic publishing 🧑‍💻📊.

🔬 Research Focus

Mr. Mohammed Amine Zitouni’s research focuses on the synthesis and characterization of biopolymer-based hydrogels for pharmaceutical applications 🧪💊. He develops advanced drug delivery systems using crosslinked chitosan and polyvinyl alcohol (PVA), aiming to enhance controlled release of antibiotics such as chlorotetracycline hydrochloride 🔄🧫. His work explores the physicochemical interactions within hydrogels to optimize stability, biocompatibility, and drug release efficiency 📈🧬. This research holds significant promise for medical treatments requiring sustained delivery mechanisms and aligns with sustainable, biodegradable material innovation 🌱🔍. His expertise contributes to the intersection of polymer science and biomedical engineering 🧠🏥.

📘 Publications

Preparation and characterization of hydrogels based on Chitosan/polyvinyl alcohol blends
Journal: Advanced Materials Research
Focus: Synthesis and structural analysis of biocompatible hydrogels for advanced material applications.
🧪💧

Release of Chlorotetracycline Hydrochloride From Novel Hydrogels Based On Crosslinked Chitosan And PVA
Journal: Annales Pharmaceutiques Françaises
Focus: Controlled drug release systems using crosslinked hydrogels for pharmaceutical applications.
💊🧬📗

Ann Kurian | Biomaterials | Best Researcher Award

Posted on by sciencefather

Ms. Ann Kurian | Biomaterials | Best Researcher Award

Ann Anu Kurian is a biomedical researcher with over seven years of experience specializing in cellular biology and RNA-based gene delivery. She holds an MS in Biomedical Science from Morehouse School of Medicine and a BTech in Biotechnology from Lovely Professional University. Currently an Associate Researcher II and Lab Manager at the Icahn School of Medicine at Mount Sinai, her work focuses on cardiac and skeletal muscle regeneration using modified mRNA technologies. She has contributed to multiple peer-reviewed publications and has been recognized with several academic honors, including a Presidential Scholarship and research presentation awards.

Ms.Ann Kurian , Icahn school of medicine, United States.

Profile

GOOGLESCHOLAR

SCOPUS

🎓 Education

Ann Anu Kurian holds a Master of Science in Biomedical Science from Morehouse School of Medicine in Atlanta, Georgia, completed between August 2015 and May 2017. She also earned a Bachelor of Technology in Biotechnology from Lovely Professional University in India, where she studied from August 2009 to May 2013.

🌟 Experience

With over seven years of research experience, Ann currently serves as an Associate Researcher II and Research Lab Manager at the Icahn School of Medicine at Mount Sinai in New York. Since November 2023, she has been working in the Gregorio Laboratory, conducting research focused on understanding the components and molecular mechanisms that regulate actin architecture in cardiac and skeletal muscle during both normal development and disease. Prior to this, she held a similar role in the Zangi Laboratory from August 2017 to November 2023, where she led projects utilizing modified mRNA to improve cardiac outcomes post-injury and managed various aspects of laboratory operations. Her professional journey began in India at VWR International from January 2014 to August 2015, where she supported chemical projects, maintained product data in SAP, and enhanced product descriptions.

🏅 Awards and Honors

Ann has been recognized for her academic and research achievements, receiving a Presidential Scholarship from Morehouse School of Medicine in 2017. The same year, she earned a travel award to attend the Georgia Academy of Science annual meeting. She also presented her research at several prestigious conferences, including the Ninth AACR Conference on The Science of Cancer Health Disparities, the Curtis L. Parker Student Research Symposium, and the Georgia Academy of Science annual meeting.

📖Skill

Ann is skilled in a wide range of technical and laboratory techniques. Her expertise includes molecular biology methods such as PCR, gel electrophoresis, cloning, RNA and DNA extraction, modified mRNA production, and LNP characterization. She is proficient in cell culture techniques, cardiomyocyte isolation, tissue sectioning, histological staining, and confocal microscopy. Her experience also includes data analysis, IVIS imaging, and statistical evaluation. She has strong capabilities in animal handling and laboratory management, including procurement, equipment maintenance, and regulatory compliance.

🔬 Research Focus

Ann’s research centers on cellular biology and RNA-based gene delivery systems, particularly in the context of cardiac and skeletal muscle biology. Her work has explored the use of modified mRNA technologies to induce gene expression for therapeutic regeneration following cardiac injury. Her contributions to the field are reflected in numerous peer-reviewed publications, addressing areas such as cardiomyocyte proliferation, ischemic injury, cardiac regeneration, and mRNA optimization.

📘 Publications

Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration
Authors: A Magadum, N Singh, AA Kurian, I Munir, T Mehmood, K Brown, …
Year: 2020
Journal: Circulation (Volume 141, Issue 15, Pages 1249–1265)

Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction
Authors: Y Hadas, AS Vincek, E Youssef, MM Żak, E Chepurko, N Sultana, …
Year: 2020
Journal: Circulation (Volume 141, Issue 11, Pages 916–930)

Ablation of a single N-glycosylation site in human FSTL 1 induces cardiomyocyte proliferation and cardiac regeneration
Authors: A Magadum, N Singh, AA Kurian, MTK Sharkar, E Chepurko, L Zangi
Year: 2018
Journal: Molecular Therapy – Nucleic Acids (Volume 13, Pages 133–143)

Optimization of 5′ untranslated region of modified mRNA for use in cardiac or hepatic ischemic injury
Authors: N Sultana, Y Hadas, MTK Sharkar, K Kaur, A Magadum, AA Kurian, …
Year: 2020
Journal: Molecular Therapy Methods & Clinical Development (Volume 17, Pages 622–633)

Direct reprogramming induces vascular regeneration post muscle ischemic injury
Authors: K Kaur, Y Hadas, AA Kurian, MM Żak, J Yoo, A Mahmood, H Girard, …
Year: (Year not provided)
Journal: Molecular Therapy (Volume 29, Issue 10, Pages 3042–3058)

Dr Feryal Akay | Biomaterials | Best Researcher Award

Posted on by sciencefather

Dr Feryal Akay | Biomaterials | Best Researcher Award

Dr. Feryal Akay is a PhD graduate in Chemistry from Dicle University (2023), specializing in human immunoglobulin G glycation and the effects of Morus nigra leaf extract on DNA glycation. She has participated in key national projects and has contributed to high-impact publications in journals like Archives of Biochemistry and Biophysics (2025) and Indian Journal of Biochemistry and Biophysics (2024). With experience as an Ar-Ge specialist at Labixir, Dr. Akay is deeply committed to advancing glycation research and is a strong candidate for the Best Researcher Award. 📚🧬🌿

Dr Feryal Akay, University of Dicle, Turkey

Profile

ORCID

SCOPUS

Education🎓

Dr. Feryal Akay completed her PhD in Chemistry at Dicle University in 2023, with a thesis on the glycation of human immunoglobulin G and its impact on antigen binding, supervised by Prof. Dr. Göksel Kızıl and Prof. Dr. Beran Yokuş. She also earned her Master’s in Chemistry from the same university in 2018, focusing on the effects of Morus nigra leaf ethanol extract on DNA glycation. Dr. Akay completed her Bachelor’s degree in Chemistry in 2015 at Dicle University’s Faculty of Science. 🎓🧪📜

Experience🩺

Dr. Feryal Akay worked as an Ar-Ge (Research and Development) Specialist at Labixir, a pharmaceutical analysis laboratory, from November 2021 to August 2022. In this role, she contributed to various research and development projects, specializing in pharmaceutical analysis and innovative techniques in the field. Her work involved analyzing and improving the efficacy of pharmaceutical products, contributing to the advancement of the pharmaceutical industry. Dr. Akay’s experience in this commercial sector allowed her to apply her academic expertise in a practical, real-world environment, further enhancing her skill set in both research and pharmaceutical development. 💊🔬🧪

Certificate 🏅

Dr. Feryal Akay has earned several prestigious certificates for her participation in international conferences. She attended the 1st International Multidisciplinary Cancer Research Congress held at Dicle University in Diyarbakır from 18-22 September 2019. She also participated in the INESEC 2018, The International Engineering Natural Science Conference, from 14-17 November 2018. Additionally, Dr. Akay presented a Oral Presentation at the 6th International Congress on Pharmaceutical Chemistry in Antalya/Belek, held by Atatürk University and the Chemists Association, from 22-25 March 2018. 🏅🎓🌍📚

Research Focus 🔬

Dr. Feryal Akay’s research primarily focuses on glycation and its impact on immune function. Her studies explore how fructose-derived glycation affects antigen binding in human IgG and lymphocytes, aiming to better understand the role of glycation in immune responses (Archives of Biochemistry and Biophysics, 2025). Additionally, Dr. Akay has investigated the inhibitory effects of Morus nigra leaf extract on DNA glycation and its potential in preventing advanced glycation end products (Indian Journal of Biochemistry and Biophysics, 2024). Her work also includes the antiglycative effects of Capsicum annuum (chili) and pyridoxamine in experimental diabetes models (Revista Brasileira de Farmacognosia, 2023). 🌱🧬🔬

Publications📚

Fructose-derived glycation and immune function: Effects on antigen binding in human IgG and lymphocytes 🧬

  • Authors: Feryal Akay, Nesrin İnceören, Cemal Nas, Beran Yokuş, Göksel Kızıl, Murat Kızıl
  • Journal: Archives of Biochemistry and Biophysics

Evaluation of ethanol extract of Morus nigra L. as an inhibitory agent for DNA-Advanced glycation end product (DNA-AGEs) 🍃

  • Authors: Feryal Akay
  • Journal: Indian Journal of Biochemistry and Biophysics

Antiglycative Effect of Combination of Extracts of Capsicum annuum (chilli) and Pyridoxamine Against Glycation in Streptozotocin-induced Experimental Diabetes in Rats 🌶️

  • Authors: Nesrin İnceören, Feryal Akay, Cemal Nas, Engin Deveci, Göksel Kızıl, Murat Kızıl
  • Journal: Revista Brasileira de Farmacognosia

Determination Of Antioxidant Activity of Dietary Selenium, Oleuropein, Glutathione Mixture 🥗

  • Authors: Feryal Akay, Göksel Kızıl
  • Journal: European Journal of Technic

Dr Xiong-Xin Lei | Biomaterials | Best Researcher Award

Posted on by sciencefather

Dr Xiong-Xin Lei | Biomaterials | Best Researcher Award

Dr Xiong-Xin Lei, First People’s Hospital of Foshan, China

Dr. Xiong-Xin Lei, a distinguished postdoctoral researcher at the First People’s Hospital of Foshan, holds a Ph.D. in Medicine from Sichuan University. With expertise in functional hydrogels, his groundbreaking research focuses on innovative applications in endoscopic treatments, hemostasis, and wound repair. Over the last five years, Dr. Lei has authored eight high-impact papers in prestigious journals like Bioactive Materials and Advanced Science. His dedication to innovation is evident in his seven granted patents, making significant strides in biomaterials and regenerative medicine. Dr. Lei’s work exemplifies excellence in bridging science and clinical applications

Publication Profile

Scopus

Academic Background🎓

Dr. Xiong-Xin Lei has a strong academic background in medicine and biomedical engineering. 🎓 He is currently a Post-Doctoral Fellow at the First People’s Hospital of Foshan, China, since August 2022. 🏥 Dr. Lei earned his Doctor of Medicine degree from Sichuan University (2019–2022), specializing in microbiology and biochemical pharmacy. 🔬 He also holds a Master of Medicine degree (2015–2017) and a Bachelor of Engineering degree (2011–2015) from Beijing University of Chinese Medicine, focusing on biopharmaceuticals and biomedical engineering, respectively. 💊 His expertise combines advanced medicine and engineering techniques for innovative healthcare solutions. 🌟

Research Focus Area 🌱🧬

Dr. Xiong-Xin Lei specializes in the development, design, and application of functional hydrogels for biomedical purposes. 🧬 His research focuses on innovative solutions for endoscopic treatments of the digestive tract, hemostasis, and wound repair. 🩺 Over the past five years, he has made significant contributions, publishing 8 research papers in prestigious journals such as Bioactive Materials, Advanced Science, and Chemical Engineering Journal. 📚 Additionally, Dr. Lei holds 7 granted invention patents, reflecting his innovative approach to medical applications of hydrogels. 💡 His work bridges materials science and regenerative medicine for advanced healthcare solutions. 🌟

Notable Achievements

Dr. Xiong-Xin Lei has achieved remarkable success in his research career over the past five years. 🌟 He has authored eight high-impact research papers published in prestigious journals such as Bioactive Materials, Advanced Science, and Chemical Engineering Journal. 📚 His groundbreaking studies have made significant contributions to the fields of regenerative medicine and smart materials, particularly in developing innovative hydrogels for medical applications. 🧬 Dr. Lei’s work highlights his dedication to advancing healthcare solutions through cutting-edge research, earning him recognition as a leader in his field. 🩺✨

Publication Top Notes🌟📊📚

Multi-crosslinking hydrogels with robust bio-adhesion and pro-coagulant activity for first-aid hemostasis and infected wound healing

A Self-Assembly Pro-Coagulant Powder Capable of Rapid Gelling Transformation and Wet Adhesion for the Efficient Control of Non-Compressible Hemorrhage

Application of metabolomics in urolithiasis: the discovery and usage of succinate

Multifunctional two-component in-situ hydrogel for esophageal submucosal dissection for mucosa uplift, postoperative wound closure and rapid healing

Click-crosslinked in-situ hydrogel improves the therapeutic effect in wound infections through antibacterial, antioxidant and anti-inflammatory activities

Scarless Healing of Injured Vocal Folds Using an Injectable Hyaluronic Acid-Waterborne Polyurethane Hybrid Hydrogel to Tune Inflammation and Collagen Deposition

Promotion of right ventricular outflow tract reconstruction using a novel cardiac patch incorporated with hypoxia-pretreated urine-derived stem cells

 

 

Prof. Dr Yusuf ÖZCAN | Biomaterials | Best Researcher Award

Posted on by sciencefather

Prof. Dr Yusuf ÖZCAN | Biomaterials | Best Researcher Award

Prof. Dr Yusuf ÖZCAN, Pamukkale University, Turkey

Prof. Özcan is a leading expert in bio-inspired nanomaterials and drug delivery systems, with a focus on advancing both biomedical engineering and environmental sustainability. His pioneering research has led to significant breakthroughs in the development of innovative materials that address critical health challenges and environmental concerns. With a proven track record of successful projects and publications, Prof. Özcan is known for his leadership in the field and his ability to bridge the gap between cutting-edge science and practical applications. His work continues to shape the future of healthcare and environmental solutions. 🌱🔬💉

Publication Profile

GoogleScholar

Orcid

Educational Background 🎓

Prof. Yusuf Özcan holds an M.S. and Ph.D. in Physics Engineering from Hacettepe University, Ankara, Turkey, where he gained expertise in advanced materials and their applications. He completed his B.S. in Physics at Atatürk University, Erzurum, Turkey. Prof. Özcan is currently an Associate Professor at Pamukkale University, Faculty of Technology, Department of Biomedical Engineering, where he has been shaping the future of biomedical technologies since 1992. Additionally, he has collaborated internationally, contributing to research at the National Synchrotron Radiation Research Center in Hsinchu, Taiwan, in 2006-2007. His diverse educational background fuels his innovative research in biomedical engineering. 🎓🔬🌍

Professional Experience and Contributions 💼

Prof. Yusuf Özcan is a distinguished Professor of Biomedical Engineering at Pamukkale University, with over 20 years of expertise in advanced material science. He holds a Bachelor’s in Physics from Atatürk University and a Ph.D. in Physical Engineering from Hacettepe University. His research spans stimuli-responsive polymers, bone tissue engineering, nanocomposites for drug release, and synchrotron-based nanomaterial analysis. Notable works include developing bio-nanocomposites for bone regeneration, hybrid hydrogels for controlled drug release, and eco-friendly biosensors for heavy metal detection. Prof. Özcan’s groundbreaking contributions have advanced biomedical engineering, nanotechnology, and environmental sustainability. 🎓🔬🌱

Research and Innovations

Prof. Yusuf Özcan has led over 20 national and international research projects, including TÜBİTAK and SESAME-supported studies, with an h-index of 10 and over 390 citations. His research focuses on biomedical engineering, nanocomposites, and stimuli-responsive polymers. He has published over 30 peer-reviewed articles in high-impact journals, and is actively working on bio-inspired nanomaterial patents. With collaborations across the globe, including Taiwan’s National Synchrotron Radiation Research Center (NSRRC), Prof. Özcan has made significant strides in advanced drug delivery systems and eco-friendly materials. He is also a member of the Turkish Physical Society. 🔬🌍📚

Research Focus Area 🌱🧬

Prof. Yusuf Özcan’s research primarily focuses on biomedical engineering, nanotechnology, and material science. His work includes the development of advanced biopolymeric nanomaterials for controlled drug delivery systems, innovative bone tissue scaffolds, and eco-friendly biosensors. Prof. Özcan specializes in stimuli-responsive polymers, nanocomposites, and synchrotron-based material analysis. He has made significant contributions to environmental sustainability by creating green materials and eco-friendly sensors for detecting heavy metals. His research extends to the development of hybrid films and microbeads for targeted drug release, enhancing the efficiency of therapeutic treatments. 🧬💊🌿

Publication Top Notes

Structure, antibacterial activity and theoretical study of 2-hydroxy-1-naphthaldehyde-N-methylethanesulfonylhydrazone

Synthesis, characterization, biological activities of dimethyltin (IV) complexes of Schiff bases with ONO-type donors

Characterization and Production of Extracellular Polysaccharides (EPS) by Bacillus Pseudomycoides U10

Structure and characterization of N-(2-hydroxy-1-naphthylidene) threonine

Structural and spectroscopic characteristics of two new dibenzylbutane type lignans from Taxus baccata L.

Crystallographic report: Bis {µ‐[O‐cyclopentyl (4‐methoxyphenyl) dithiophosphonato] 1κ: S, 2κ: S‐[O‐cyclopentyl (4‐methoxyphenyl) dithiophosphonato]‐1κ2S, S′} dicadmium (II)

STRUCTURAL, ELECTRICAL AND OPTICAL PROPERTIES OF THERMALLY EVAPORATED CdSe AND In-DOPED CdSe THIN FILMS.

Micellization behavior of tertiary amine-methacrylate-based block copolymers characterized by small-angle X-ray scattering and dynamic light scattering

trans-Bis [O-2, 4-di-tert-butylphenyl (4-methoxyphenyl) dithiophosphonato-κ2S, S′] nickel (II)

Crystal and Molecular Structures of trans-Nickel (II)-bis [(O-propyln)-(p-methoxyphenyl) dithiophosphonate]

Conclusion

Prof. Dr. Yusuf Özcan’s extensive body of work demonstrates not only scientific excellence but also practical contributions to pressing global challenges, making him a strong and deserving candidate for this award. His innovative approach and global collaboration signify a researcher who is pushing the boundaries of materials science and biomedical engineering.

Dr Markus Laubach | Biomaterials | Best Researcher Award

Posted on by sciencefather

Dr Markus Laubach | Biomaterials | Best Researcher Award

Dr Markus Laubach, LMU University Hospital Munich, Germany

Dr. Markus Laubach 🎓🩺 is a distinguished researcher in orthopaedics and medical innovation. Holding a Ph.D. in preclinical assessment of novel medical devices, an MBA in Healthcare Management, and certifications in emergency medicine, he combines clinical expertise with research excellence. 🏥🔬 His groundbreaking work focuses on scaffold-guided bone regeneration, 3D-printed implants, and bone grafting techniques, published in top journals like Biomaterials Science and Scientific Reports. 💡📚 Dr. Laubach has secured over EUR 350,000 in grants and won prestigious awards, including the Best Poster Award at DKOU 2023. 🌍 He actively collaborates globally, advancing orthopaedic trauma care. 🦴✨

Publication Profile

Orcid

Scopus

Education and Training🎓

Dr. Markus Laubach 🎓 began his educational journey at Stefan-George-Gymnasium, earning his Abitur in 2007 🎒. He trained as a paramedic 🚑 at Arbeiter-Samariter-Bund in 2008. He pursued Medicine 🩺 at Maastricht University (2010–2016) and earned his Dr. med. from Charité Berlin in 2019 📚, focusing on brain aging and executive functioning 🧠. Further, he specialized in Emergency Medicine 🚨 and completed his Ph.D. at QUT 🦴 (2020–2023), researching bone graft aspirator devices. Recently, he earned an MBA 🎓 in Health Care Management 🏥. Currently, he advances orthopaedic research at LMU Munich through the prestigious Feodor Lynen Fellowship 🌍.

Professional Experience💼

Dr. Markus Laubach 🩺 has extensive professional experience in orthopaedics and trauma surgery. He is currently a Resident at the LMU University Hospital 🏥, Musculoskeletal University Center Munich (2023–present). Previously, he worked as a Resident at RWTH Aachen University Hospital (2016–2020) 🦴, advancing his surgical expertise. Dr. Laubach further honed his skills in medtech commercialization through The BridgeTech Program 🌐 in Australia (2021–2022). His medical journey began as a Paramedic 🚑 with organizations like Malteser Hilfsdienst (2011–2016), Arbeiter Samariter Bund (2009–2010), and DRK Rettungsdienst GmbH (2008–2009), reflecting his dedication to emergency medical care and patient well-being 🤝.

Research Focus Area 🌱🧬

Markus Laubach is a researcher specializing in biomaterials, bone regeneration, and spinal surgery innovations. His work primarily focuses on advancing implants, scaffolds, and bone grafts for clinical applications, particularly in lumbar spinal fusion and bone defect treatments. He is involved in designing 3D printable, patient-specific bioresorbable bone scaffolds to promote bone regeneration. Laubach’s research extends to the development of novel bone graft harvesting techniques and the assessment of biodegradable interbody cages. His work intersects with orthopaedic trauma, regenerative medicine, and biomechanics. 🦴🧬🩺

Memberships

Dr. Markus Laubach is an active member of several prestigious medical and research organizations. He is affiliated with AO Trauma 🦵, focusing on advancing trauma care, and the Deutsche Gesellschaft für Orthopädie und Unfallchirurgie (DGOU) 🇩🇪, which promotes orthopedic and trauma surgery excellence. He also participates in the Gesellschaft für Extremitätenverlängerung und -rekonstruktion (GEVR) 🦴, dedicated to extremity reconstruction. Additionally, Dr. Laubach is a member of the Orthopaedic Research Society (ORS) 🔬 and the Tissue Engineering and Regenerative Medicine International Society (TERMIS) 🌍, contributing to cutting-edge research in tissue engineering and regenerative medicine.

Awards🏆

Dr. Markus Laubach has received notable recognition for his scientific contributions. In 2023, he was awarded the Best Poster Award at the DKOU 2023 in Berlin 🏆. His research has attracted competitive grants, including EUR 182,022.36 from the Bundesministerium für Bildung und Forschung for a clinical study on tibial transverse callus distraction in diabetic foot ulcer patients 💉, and EUR 39,600 from the Feodor Lynen Return Fellowship 🏅. Dr. Laubach also secured funding from the Volkswagen Foundation (EUR 38,000) and Clive & Vera Ramaciotti Foundation (AUD 130,000) for innovative bone defect treatments using 3D-printed scaffolds.

Publication Top Notes📄✨

Advances in implants and bone graft types for lumbar spinal fusion surgery

Modular design workflow for 3D printable bioresorbable patient-specific bone scaffolds: extended features and clinical validation.

Preclinical assessment of a novel aspirator device for intramedullary bone graft harvesting

Lost in translation: the lack of agreement between surgeons and scientists regarding biomaterials research and innovation for treating bone defects

An innovative intramedullary bone graft harvesting concept as a fundamental component of scaffold-guided bone regeneration: A preclinical in vivo validation

Chirurg*innen vs. Wissenschaftler*innen – Mind the Gap! DKOU Science-Slam 2023: Umfragestudie zu Biomaterialien bei Knochendefekten [Surgeons vs. scientists—Mind the gap!: Survey study on biomaterials for bone defects]

How framing bias impacts preferences for innovation in bone tissue engineering

Semi-automated scaffold design workflow to facilitate clinical translation of scaffold guided bone regeneration

The development of a modular design workflow for 3D printable bioresorbable patient-specific bone scaffolds to facilitate clinical translation

Histological and Immunohistochemical Characterization of Osteoimmunological Processes in Scaffold-Guided Bone Regeneration in an Ovine Large Segmental Defect Model

Conclusion

Dr. Markus Laubach’s robust academic foundation, exceptional research achievements, successful funding track record, and dedication to clinical translation make him an excellent candidate for the Best Researcher Award. His work directly addresses critical gaps in bone defect treatments, contributing both to scientific innovation and practical healthcare advancements.

Dalia Zaafar | Biomaterials | Women Researcher Award

Posted on by sciencefather

Dalia Zaafar | Biomaterials | Women Researcher Award

Assist. Prof. Dr Dalia Zaafar, Cairo University, Egypt

Dr. Dalia Zaafar is an Assistant Professor at Modern University for Technology and Information (MTI) in Egypt, specializing in pharmacology, toxicology, and clinical pharmacy. With a Ph.D. from Cairo University, she has led impactful research on cardiovascular pharmacology and oncology. 🌍 Her work includes clinical studies, focusing on metformin and sorafenib, contributing to drug safety. Dr. Zaafar is passionate about mentoring young researchers, especially women in academia, and has presented at international conferences. 🎓 She holds certifications in clinical practice and data analysis, enhancing her role as an expert in her field. 📚

Publication Profile

Google Scholar

Orcid

Scopus

Educational Background 🎓

Dr. Dalia Zaafar holds a Ph.D. in Pharmacology and Toxicology from Cairo University (2019), with a focus on clinical studies and cardiovascular pharmacology. Her dissertation explored the efficacy and safety of dipeptidyl peptidase inhibitors versus Metformin in diabetic hypertensive patients. 🎓 She earned an M.A. in Pharmacology and Toxicology from Suez Canal University (2014), specializing in oncology and endocrinology. Dr. Zaafar also completed a Clinical Pharmacy diploma (2019-2021) in critical care and further honed her skills through a Data Analysis Professional Nano-degree (2021) and other specialized certifications in clinical pharmacology and pharmacoeconomics. 📚💻

Current Role and Focus 💼

Dr. Dalia Zaafar is an Assistant Professor at the Modern University for Technology and Information (MTI), Egypt, where she has been teaching and conducting research since 2019. 🌟 She designs experimental studies, collaborates internationally, and mentors young researchers. Additionally, she serves on the editorial boards of the Universal Journal of Pharmaceutical Research and the World Journal of Clinical Cases. 📘 Previously, she worked as a Clinical Pharmacist in critical care at Teacher’s Hospital and Abu Sower Medical Center. Dr. Zaafar has expertise in clinical pharmacy, research supervision, and interdisciplinary initiatives, fostering academic growth and innovation. 🧪👩‍🏫

Participation in Conferences 🌐

Dr. Dalia Zaafar was a speaker at the 18th International Conference of Biochemistry and Molecular Biology, held on September 16-17, 2023. 🌍 Her lecture, titled “Unravelling the Complexities of Tau Protein Dysfunction in Alzheimer’s Disease: Pathophysiology, Biomarkers, and Therapeutic Perspectives”, highlighted groundbreaking insights into the mechanisms of Alzheimer’s disease. 🧠🔬 She discussed emerging biomarkers and innovative therapeutic strategies, contributing to a deeper understanding of this critical neurodegenerative condition. Dr. Zaafar’s presentation underscored her expertise in molecular biology and her dedication to advancing research for a better future for humanity. 🌟

Research Focus Area 🌱🧬

Dr. Dalia Zaafar’s research is focused on pharmacology, toxicology, and clinical pharmacy, with a multidisciplinary approach to tackling critical health challenges. 🧪 Her studies emphasize drug safety, cardiovascular pharmacology, and oncology, exploring innovative therapeutic interventions for diseases like Alzheimer’s, Parkinson’s, colon cancer, and drug-induced toxicities. 🔬 Her work integrates molecular biology, nanotechnology, and experimental pharmacology, addressing mechanisms like tumor angiogenesis, neuroprotection, and signal pathway modulation. 🌍 Dr. Zaafar’s impactful contributions also span natural product-based therapies, nanoparticles for drug delivery, and biomarker development, making her a pioneer in advancing personalized medicine and enhancing treatment efficacy. 🌟

Publication Top Notes📚🌐

Role of metformin in suppressing 1, 2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation

Hesperetin mitigates sorafenib-induced cardiotoxicity in mice through inhibition of the TLR4/NLRP3 signaling pathway

Selenium nanoparticles with prodigiosin rescue hippocampal damage associated with epileptic seizures induced by pentylenetetrazole in rats

Orexin pathway in Parkinson’s disease: a review

Discovery of new 1, 3, 4-oxadiazoles with dual activity targeting the cholinergic pathway as effective anti-Alzheimer agents

Comparing the effectiveness of L-carnitine and paraffin oil in acute aluminum phosphide poisoning using predictive biomarkers and scores: a randomized controlled clinical trial

Adherence to insulin therapy among children with type 1 diabetes: reliability and validity of the Arabic Version of the 4-Item Morisky Medication Adherence Scale

Combined β-sitosterol and trimetazidine mitigate potassium dichromate-induced cardiotoxicity in rats through the interplay between NF-κB/AMPK/mTOR/TLR4 and HO-1/NADPH signaling …

Salix subserrata Bark Extract–Loaded Chitosan Nanoparticles Attenuate Neurotoxicity Induced by Sodium Arsenate in Rats in Relation with HPLC–PDA-ESI–MS …

Conclusion 🔍

Dr. Dalia Zaafar’s dedication to research excellence, her leadership in mentoring young women researchers, and her impressive body of scholarly work make her a highly suitable candidate for the Women Researcher Award. Her contributions to pharmacology, particularly in clinical studies, and her active role in global research collaborations position her as an influential figure in the academic community.